Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Galvus Trial To Take Longer Than Predicted; Novartis Also Sees Tasigna Delay

Related Content

Galvus “Approvable”: Additional Trial To Be Relatively Small, Short – Novartis

Mar 05 2007

Skin Toxicity Seen In Other DPP-4 Inhibitors Missing In Januvia – FDA Review

Feb 19 2007

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window